These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29569032)

  • 1. 2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy.
    Funabashi N; Takaoka H; Ozawa K; Uehara M; Komuro I; Kobayashi Y
    Heart Vessels; 2018 Sep; 33(9):1046-1051. PubMed ID: 29569032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Differentiation of LV Myocardium with and without Layer-Specific Fibrosis Using MRI in Hypertrophic Cardiomyopathy and Layer-Specific Strain TTE Analysis.
    Funabashi N; Takaoka H; Ozawa K; Kamata T; Uehara M; Komuro I; Kobayashi Y
    Int Heart J; 2018 May; 59(3):523-530. PubMed ID: 29743413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT.
    Yajima R; Kataoka A; Takahashi A; Uehara M; Saito M; Yamaguchi C; Lee K; Komuro I; Funabashi N
    Int J Cardiol; 2012 Jul; 158(3):423-32. PubMed ID: 21354635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocardial Fibrotic Lesions Have a Greater Effect on Peak Longitudinal Strain than Epicardial Fibrotic Lesions in Hypertrophic Cardiomyopathy Patients.
    Funabashi N; Takaoka H; Ozawa K; Kobayashi Y
    Int Heart J; 2018 Mar; 59(2):347-353. PubMed ID: 29479007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early marker of regional left ventricular deformation in patients with hypertrophic cardiomyopathy evaluated by MRI tissue tracking: The effects of myocardial hypertrophy and fibrosis.
    Xu HY; Chen J; Yang ZG; Li R; Shi K; Zhang Q; Liu X; Xie LJ; Jiang L; Guo YK
    J Magn Reson Imaging; 2017 Nov; 46(5):1368-1376. PubMed ID: 28370909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationship between the Myocardial Mass, Fibrosis, BNP, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
    Miyaji Y; Iwanaga Y; Nakamura T; Yasuda M; Kawamura T; Miyazaki S
    Intern Med; 2016; 55(10):1261-8. PubMed ID: 27181530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
    Chang SA; Lee SC; Choe YH; Hahn HJ; Jang SY; Park SJ; Choi JO; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Dec; 28 Suppl 2():133-40. PubMed ID: 23097128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.
    Windram JD; Benson LN; Dragelescu A; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Congenit Heart Dis; 2015; 10(6):E258-67. PubMed ID: 26193909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis.
    Galli E; Vitel E; Schnell F; Le Rolle V; Hubert A; Lederlin M; Donal E
    Echocardiography; 2019 Jan; 36(1):74-82. PubMed ID: 30488501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful MACE risk stratification in hypertrophic cardiomyopathy patients using different 2D speckle-tracking TTE approaches.
    Ozawa K; Funabashi N; Takaoka H; Kobayashi Y
    Int J Cardiol; 2017 Feb; 228():1015-1021. PubMed ID: 27931009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.